NKGen Biotech (NKGN) Stock Price

NKGen Biotech Price

NYSE·CLOSED
0.01
​
Market closed

NKGen Biotech's net margin stands at -34,745.5%, down from -5,461.3% several years earlier.

NKGen Biotech stock price

Access this data via the Eulerpool API

NKGen Biotech business model & stock analysis

NKGen Biotech Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Santa Ana, California. The company went IPO on 2021-05-21. NKGen Biotech, Inc. is a clinical-stage biotechnology company. The firm is focused on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing its (SuperNK) SNK (super-activated) platform. SNK involves the infusion of one’s own activated NK cells into the body to improve immune system function, eliminate diseased or abnormal cells and prevent recurrence. SNK uses pure NK cells harvested from the patient’s blood, activated and infused back into the patient’s body. SNK has a therapeutic potential within the areas of cancer, autoimmune and neurodegenerative diseases. Autologous NK cell immunotherapy is a treatment that provides immune enhancement using pure NK cells harvested from a patient’s body. The company is also focused on conducting clinical trials with its super-activated NK cell therapy in patients with neurodegenerative disease (SNK01) and cancer (SNK02).

Frequently asked questions about NKGen Biotech

Converted at the current exchange rate, the NKGen Biotech share trades at 0.01 EUR (0.01 USD).

The revenue cannot currently be calculated for NKGen Biotech.

The profit cannot currently be calculated for NKGen Biotech.

The P/E ratio cannot be calculated for NKGen Biotech at the moment.

The P/S cannot be calculated for NKGen Biotech currently.

The Eulerpool Quality Score for NKGen Biotech is 2/10.

The ISIN of NKGen Biotech is US65488A1016. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of NKGen Biotech is NKGN. The ticker symbol is used to trade NKGen Biotech shares on the stock exchange.

Fair ValueTerminal
0.01 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
May 21, 2021
ISIN
US65488A1016
Cusip
65488A101
Market capitalization
1.44 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.92
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
213.95 %
Last updated Oct 8, 2026, 6:43 AM

NKGen Biotech Peer Group

NKGen Biotech FIGI

NKGN:US · BBG00ZFCTT22NKGN:UA · BBG011MNM3S0NKGN:UC · BBG011MNM3T9NKGN:UN · BBG011MNM3W5NKGN:UP · BBG011MNM3X4NKGN:UQ · BBG011MNM3Y3NKGN:UB · BBG011MNM3Z2NKGN:UM · BBG011MNM417NKGN:UX · BBG011MNM426NKGN:UD · BBG011MNM471NKGN:UF · BBG011MNM4B6NKGN:VY · BBG011MNM4C5